chloroquine has been researched along with Necrobiosis Lipoidica in 3 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Necrobiosis Lipoidica: A degenerative disease of the dermal connective tissue characterized by the development of erythematous papules or nodules in the pretibial area. The papules form plaques covered with telangiectatic vessels. More than half of the affected patients have diabetes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ZIEKUR, U | 1 |
| Durupt, F | 1 |
| Dalle, S | 1 |
| Debarbieux, S | 1 |
| Balme, B | 1 |
| Ronger, S | 1 |
| Thomas, L | 1 |
| Nguyen, K | 1 |
| Washenik, K | 1 |
| Shupack, J | 1 |
1 review available for chloroquine and Necrobiosis Lipoidica
| Article | Year |
|---|---|
Necrobiosis lipoidica diabeticorum treated with chloroquine.
Topics: Antirheumatic Agents; Chloroquine; Dermatologic Agents; Female; Humans; Middle Aged; Necrobiosis Lip | 2002 |
2 other studies available for chloroquine and Necrobiosis Lipoidica
| Article | Year |
|---|---|
[THERAPEUTIC EXPERIENCES WITH RESOCHIN AND RESOCHIN-CONTAINING PREPARATIONS IN DERMATOLOGICAL PATIENTS].
Topics: Carcinoma, Squamous Cell; Chloroquine; Drug Eruptions; Drug Therapy; Finger Injuries; Hematoma; Herp | 1964 |
Successful treatment of necrobiosis lipoidica with antimalarial agents.
Topics: Adult; Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Drug Administration Schedule; F | 2008 |